Cramer's View on Clover Health, UnitedHealth, and CVS
Finance

Cramer's View on Clover Health, UnitedHealth, and CVS

authorBy Nouriel Roubini
DateJun 20, 2026
Read time2 min
This article examines Jim Cramer's analysis of Clover Health (CLOV) in comparison to UnitedHealth (UNH) and CVS, as discussed on his show, "Mad Money." It explores his perspective on CLOV as a speculative investment versus the long-term stability offered by healthcare industry leaders.

Navigating the Market: Speculation vs. Stability in Healthcare Stocks

Cramer's Initial Assessment of Clover Health

During a segment on "Mad Money," financial commentator Jim Cramer offered his insights into Clover Health Investments, Corp. (CLOV), highlighting its status as a speculative investment. He underscored the importance of focusing on a stock's future potential rather than its historical performance.

Clover Health's Financial Performance and Cramer's Re-evaluation

A caller referenced Cramer's earlier characterization of Clover Health as speculative, noting the company's reported GAAP profitability in the first quarter of 2026 and its positive full-year profitability projections. Cramer acknowledged the validity of this point, conceding that his previous assessment might have been overly cautious.

Cramer's Preference for Established Healthcare Leaders

Despite Clover Health's recent financial improvements, Cramer reiterated his stronger preference for industry stalwarts like UnitedHealth and CVS. He emphasized that these companies offer more reliable long-term investment opportunities due to their established market positions and consistent performance.

Clover Health's Business Model and Market Dynamics

Clover Health Investments, Corp. specializes in providing preferred provider organization and health maintenance organization Medicare Advantage plans. Additionally, the company offers a software platform, Clover Assistant, which assists physicians in detecting, identifying, and managing chronic conditions. Despite its innovative approach, Cramer cautioned about the company's past quarter, which he described as not particularly strong, implying that its recent upward movement should be viewed with some skepticism.

Strategic Investment Choices: Beyond Speculation

While acknowledging the potential of speculative stocks such as Clover Health, the broader investment advice suggests considering companies with less downside risk and higher upside potential, particularly in emerging sectors like AI. The discussion implicitly encourages investors to look for robust opportunities that align with significant market trends, including those influenced by trade policies and domestic manufacturing shifts.

More Articles
Finance
Jim Cramer's Endorsement of Vistra: A "Steal" at Current Valuations
Financial commentator Jim Cramer has offered a positive outlook on Vistra Corp. (VST), an integrated energy provider, suggesting its recent stock decline presents a buying opportunity. Despite acknowledging its previous high valuation, Cramer now views Vistra as undervalued, citing its strong earnings growth and significant role in power generation, particularly with its nuclear assets and connection to the booming data center industry.
By Michele FerreroJun 20, 2026
Finance
Jim Cramer Praises SLB's Digital Business and Future Prospects
Financial analyst Jim Cramer recently lauded SLB (formerly Schlumberger) for its innovative digital business during a 'Mad Money' segment. Despite market fluctuations, Cramer highlighted SLB's cutting-edge technology in oil and gas and its potential for growth, suggesting investors focus on future trajectory over past performance.
By Robert KiyosakiJun 20, 2026
Finance
Jim Cramer Advocates for Bank Consolidations, Commends Banco Santander's Strategic Moves
Financial analyst Jim Cramer recently emphasized the importance of bank mergers, suggesting the U.S. financial landscape has an excess of banking institutions. He lauded Banco Santander's acquisition of Webster Financial, viewing it as a shrewd move capitalizing on relaxed regulatory conditions. Cramer also offered investment advice on Santander shares, recommending a purchase if the price dips to $10. He highlighted the bank's comprehensive services, including lending, wealth management, payments, and digital banking.
By Robert KiyosakiJun 20, 2026
Finance
Getty Realty: High-Yield REIT at an Attractive Price
Getty Realty offers investors a compelling blend of high yield, consistent dividend growth, and strong total returns, positioning it as an attractive option for income-focused portfolios. The company's diversified net lease portfolio, high occupancy rates, and strategic acquisitions contribute to steady growth in Funds From Operations (FFO) and dividends per share. With a robust balance sheet, substantial liquidity, and no significant debt maturities until mid-2028, the safety and reliability of its dividend are well-supported. The current valuation, at 12.6 times forward Price/FFO, appears appealing, suggesting potential for both mid-single-digit FFO growth and multiple expansion, making it a noteworthy investment opportunity in the current market.
By Strive MasiyiwaJun 20, 2026
Finance
Fox to Acquire Roku in $22 Billion Deal, Redefining Streaming Landscape
Fox Corporation has announced its intention to acquire Roku for $22 billion, a move set to transform the streaming industry. The acquisition highlights Roku's strategic value, particularly its dominant position in connected TV viewing. This deal, expected to close by the first half of 2027, suggests a ceiling on Roku's near-term stock appreciation and prompts a reevaluation of its investment outlook.
By Robert KiyosakiJun 20, 2026